Intrinsic Value of S&P & Nasdaq Contact Us

MaxCyte, Inc. MXCT NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
48/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$6.00
+609.9%

Stock Statistics — MXCT

MaxCyte, Inc. (MXCT) has a market capitalization of $90.32M and trades at $0.85. The 52-week range is 0.643-2.955.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2, Earnings Per Share (EPS) of $-0.42, annual revenue of $33.03M.

The stock has a beta of 1.45, operates in the Healthcare sector.

Trading Data
Current Price$0.85
52-Week Range0.643-2.955
Volume556.01K
Avg Volume (30D)1.18M
Market Cap$90.32M
Beta (1Y)1.45
Company
IPO Date2021-07-30
Employees114
CEOMaher Masoud
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS57777K1060
CUSIP57777K106
Income (Latest Year)
Revenue$33.03M
Gross Profit$22.58M
EBITDA$-38.4M
Operating Income$-43.55M
Net Income$-44.63M
EPS$-0.42
EPS Diluted$-0.42
Shares Outstanding$106.43M
Balance Sheet (Latest Year)
Total Assets$202.51M
Current Assets$118.37M
Cash & ST Investments$103.04M
Total Liabilities$31.02M
Total Debt$17.94M
Net Debt$-2.12M
Total Equity$171.49M
Debt / Equity0.10
Valuation Ratios
P/E Ratio-2
P/S Ratio2.73
P/B Ratio0.53
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message